JZP3507 (ONC206)

ONC206 · Jazz Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JZP3507 (ONC206), covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma [Phase 2]